Tissue Diagnostics Market: Product failures and recallsPosted by Kriti on May 13th, 2021 The research study involves four major activities in estimating the current size of the tissue diagnostic market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Then, both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments. Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1063949 Major Market Growth Drivers: Revenue Growth Analysis: Based on the product, the tissue diagnostics market is segmented into instruments and consumables. The consumables segment is expected to grow at the highest growth rate during the forecast period. This is attributed primarily to their requirement in large numbers, cost-effectiveness, and ease of use. The increasing number of reagent rental agreement is also one of the major factors to drive the growth of the consumables market globally Immunohistochemistry segment to dominate the tissue diagnostics market in 2019 Based on the technology, the Tissue diagnostics product market is segmented into immunohistochemistry, in situ hybridization, digital pathology and workflow, and special staining. The immunohistochemistry segment is estimated to register the highest CAGR during the forecast period. This can primarily be attributed to the increasing prevalence of chronic diseases across the globe, where this technology is mostly used in tissue diagnostics. North America was the largest regional for tissue diagnostic market in 2019 The tissue diagnostics product market has been analyzed for North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2019, North America held the largest share of the market, followed by Europe. Easy accessibility to advanced technologies, government initiatives for screening cancer patients, favourable reimbursement scenario for pathology diagnostic tests, increasing healthcare expenditure, and high-quality infrastructure for hospitals and clinical laboratories in this region are the major factors driving the growth of the tissue diagnostic market in North America. To speak to our analyst for a discussion on the above findings, click Speak to Analyst Key Market Players: Like it? Share it!More by this author |